PLYMOUTH, MN. - Delve Health Corporation today introduced Study Pal, the industry first cloud application that provides "tip card" information (protocol overview, device/drug and procedure training material, study communications) through a mobile application. Now life science companies can easily provide key trial and product information to investigators and research staff on their smartphone.
Study Pal will help life science companies share trial and product information to investigators and research staff in an accessible format by providing:
Confidentiality – users can login to a website using an authenticated username and password and create their content
Protocol Information – Inclusion/ Exclusion Criteria and key study procedures and data collection requirements
Study Flow – create a flow chart for the study visits
Study Contact – contact study staff in one click to call, text or email directly from the app
Product and Procedure Information – upload your device animation or procedure video directly to Study Pal so investigators can share with referring physicians or patients in real-time.
Visit Schedule – allow research coordinators to create a study visit schedule to automatically calculate follow up windows for all patient visits
Calculations – provide an easy calculation tool for various elements, such as BMI
Training – easy access to all the training material
Compliance – ensure that all parties have the latest protocol revisions
Traceability – track who has logged in, ensure they have received the notifications and comply with protocol guidelines
Cloud Solution – always up to date with the latest features and content
"We were thrilled to release the Study Pal to our clinical sites," said Jennifer Englund, VP of Clinical & Regulatory Affairs at Mardil Medical. "In a time where people always have their phones with them, I am surprised our industry is still printing laminated tip cards to share study information with clinical sites. This tool allows us to share and easily update key study information, and assure there is never confusion associated with version control when protocol and procedures change. As a small company, this tool also gives us a very professional and polished way to communicate with our customers. It is a great resource for our internal team, monitors and physician advisors as well."
"Delve Health is bringing the next generation of study tips and information," said Wessam Sonbol, CEO of Delve Health. "We are fulfilling a significant gap in the industry, by providing a completely configurable mobile app, allowing sponsors and sites to ensure protocol compliance and providing easier access to information. For the first time, Life Science organizations will be able to publish protocol tips, summaries, video, study contact and more simply by the click of a button."
About Delve Health Corporation
Delve Health Corporation is a Minnesota-based technology company, which seeks to provide products through proprietary platform technologies by subscription to users who seek to streamline their research processes by using quality data to conduct faster literature reviews and clinical evaluation reports, pre-qualify sites/investigators for clinical trials or to gain an insight into the life science industry. To learn more about Delve Health, visit www.delvehealth.com or email info@delvehealth.com
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.